影响TAE治疗原发性肝癌患者生存率的因素

目的 :探讨肝癌病灶血供状态等因素对TAE治疗原发性肝癌生存率的影响。材料和方法 :回顾性分析经TAE治疗的 81例肝癌患者病灶血供状态、有无动 -静脉瘘形成和病灶大小对TAE生存率的影响 ;分析不同血供状态、病灶大小的不同碘油用量。结果 :富血供病灶者 ,6、12、18个月生存率分别为 72 %、5 3 %、48% ;中等血供病灶者 ,6、12、18个月生存率分别为 93 %、62 %、5 9% ;少血供病灶者 ,6、12、18个月生存率均为 75 %。直径小于 5cm的肿瘤 2年生存率可达 83 % ;动 -静脉瘘的存在对生存率有显著的影响。结论 :中等血供病灶和少血供病灶生存率高于富血供者 ;动 -静脉瘘对生存率有显著影响 ;直径小于 5cm肝癌的TAE治疗可获得令人满意的效果。

The Affecting Factors of the Survival of the Patients with Primary HCC

Purpose:To study the effect that such factors as blood supply put on the survival of primary HCC treated by TAE.Materials and Methods:81 patients who experienced TAE were followed up and reviewed. The survival difference caused by blood supply,AVF ,size of tumor and the difference of lipiodol quantity caused by blood supply and size of tumor was statistically analyzed respectively.Results:The survival of the patients with hypervascular was 72%,53%,48% at 6,12,18 months, with medium vascular was 93%,62%,59% at 6,12,18 months,with hypovascular was 75%,75%,75% at 6,12,18 months.The survival of the patients with tumor diameter less than 5cm arrived at 83% by 2 years.AVF had a significant effect on survival.Conclusion:The survival of the patients with medium vascular and hypovascular is longer than those with hypervascular. A satisfied survival of HCC less than 5cm is available by TAE.The survival difference between AVF and no AVF is significant.